michael davis

15
Abcd Value through Innovation ABCD

Upload: simon23

Post on 12-May-2015

362 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: Michael Davis

Abcd

Value through Innovation

ABCD

Page 2: Michael Davis

AbcdValue Through Innovation

Boehringer Ingelheim is committed to becoming the most innovative research, development and distribution enterprise in the world, providing products that significantly enhance health and quality of life.

•Currently investigating therapies for over 22 acute and chronic conditions that drive up US health care costs.

•17% net sales to R&D

Page 3: Michael Davis

Abcd

• Family owned – Boehringer

• Founded in Ingelheim / Germany in 1885

• Operating worldwide•156 affiliates in over 60 countries•35,700 employees

• Focus on Human Pharmaceuticals – 95%• Prescription medicines – Brand and Generic• Over-the-Counter medicines

BI Worldwide

Page 4: Michael Davis

AbcdPharmaceutical R&D

BIPKG(Karl Thomae)

BoehringerIngelheim

Pharmaceuticals

BI Austria

BoehringerIngelheim, KG

NipponBoehringer

(Allergy, Biotechnology)

(Immunology, Inflammation,

Cardiovascular)

(Virology)

BI Canada

(Oncology)

(Respiratory, CNS,Metabolic Diseases)

Page 5: Michael Davis

AbcdBIC Companies - 6,000 employees

Roxane Laboratories, Inc.

Columbus, OH

Boehringer Ingelheim CorporationBoehringer Ingelheim Pharmaceuticals, Inc.

BI Services Center, Inc.Boehringer Ingelheim Cares

Foundation, Inc.Ridgefield, CT

2,300 employees

BI VetmedicaSt. Joseph, MO

Boehringer Ingelheim Chemicals, Inc.Petersburg, VA

Ben Venue LabsBedford, OH

Page 6: Michael Davis

AbcdUS Statistics (2005 Projected)

Net Sales $ 4.2 billion +31%

Employees in US 6,000

Employees in Danbury/Ridgefield 2,300 +14%

Expected employee growth in CT 750(over next seven years)

Page 7: Michael Davis

AbcdProducts in the US

• Brand Prescription MedicinesChronic Obstructive SPIRIVA, COMBIVENT, ATROVENT

Pulmonary Disease Urology FLOMAXVirology (HIV/AIDS) VIRAMUNE, APTIVUSCardiology MICARDIS, AGGRENOX, CATAPRESImmunology MOBICNeurology MIRAPEX

• Generic Prescription Medicines• Over 200 products with specialties in anti–cancer, sterile

injectables and sterile respiratory therapies

• Over-the-Counter • DULCOLAX

Page 8: Michael Davis

Abcd

Assisting the Community

•Local

•National

Page 9: Michael Davis

AbcdBI Cares Foundation

The Foundation’s mission is to improve lives through innovative philanthropic contributions and donations of healthcare products and resources.

• BI Cares Foundation Patient Assistance Plan.

• Hurricane Katrina assistance.

• Product Donation Program.

Page 10: Michael Davis

AbcdCommunity Involvement - CT• Lung Health Screening Program• United Way of Northern Fairfield County• Regional Hospice of Western Connecticut• American Red Cross• Connecticut PBS – Family Science Expo• Abilities Beyond Disabilities (DATAHR)• Connecticut United for Research Excellence• Ives Center for the Arts• Girl Scout Council of SW Connecticut• Regional YMCA Center for Arts & Humanities• Special Olympics – Connecticut• Western Connecticut State University

Page 11: Michael Davis

Abcd

Growth for the Future

Page 12: Michael Davis

AbcdRidgefield campus projects

• Lead Discovery Technologies Building dedicated in 2001

• Kilo Lab• Completed in 2005, produces drug substances up to 5

kg quantities for research purposes.

• On-site Child Care Center; September 2006• 19,000 sq ft stand alone building with a capacity for

256 infants, toddlers and preschoolers.

• Physical Sciences building; March 2007• 86,000 sq ft building to accommodate relocation of

our cardiovascular diseases research program from Germany.

• 3 floors, 119 work stations for scientists and management.

Page 13: Michael Davis

AbcdNeeds for the future

•Educated workforce

•Vibrant biopharmaceutical industry in CT

•Public private sector collaborations•Clinical trials centers of excellence•IRB networks

Page 14: Michael Davis

AbcdThreats

Prescription drug importation• AKA price controls

Promotion restrictions• Inability to generate interest in new

products

Access restrictions• Inability to gain market share

Increased costs of doing business• Energy, taxes, fees, liability

Page 15: Michael Davis

AbcdWeb information

• http://www.boehringer-ingelheim.com Worldwide web

• http://us.boehringer-ingelheim.com US company web

• https://www.pparx.org/Intro.php Partnership for Prescription Assistance

• http://us.boehringer-ingelheim.com/about/philanthropy/Patient_Assistance_Program.html BI Cares Foundation Patient Assistance web